The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
Intends to Repurchase at Least $5 Billion of Common Stock by End of First Half of 2024, with Portion Executed Via ASR in First Quarter 2024 Reaffirms Previously Provided Outlook for Full-Year 2023 BLOOMFIELD, Conn., Dec. 10, 2023 /PRNewswire/ — Global health company The Cigna Group (NYSE: CI
Applicants Wanted: The Fighting and Managing Wildfire in a Changing Climate Program – Training Fund
OTTAWA, ON, Dec. 10, 2023 /CNW/ – As climate change continues to impact the frequency, intensity and severity of wildfires in many provinces and territories, the Government of Canada is continuing to support Canadians now while strengthening Canada’s preparedness for years to come. Inves
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
82% ORR and deep clinical responses from off-the-shelf, allogeneic BCMA-targeted CAR-T in heavily pretreated patients receiving adequate lymphodepletion 100% ORR in these patients who were not previously treated with a BCMA-targeted bispecific T cell-engaging antibody Favorable emerging safety and r
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Multiplex allogeneic epigenetic edits demonstrate elimination of graft-versus-host disease and resistance of CD8+T, CD4+T, and NK cell responses, while preserving genomic integrity Chroma’s allogeneic approach has the potential to drive greater persistence of a CAR T relative to current allog
Aqua Bridge Group and Enertech launch Aqua Bridge Kuwait at COP28, in boost for local food systems and fisheries
Joint venture poised to decarbonize Kuwait’s food supply chains, reinforce resource resilience of aquaculture and fisheries sectors DUBAI, UAE, Dec. 10, 2023 /PRNewswire/ — Aqua Bridge Group, a global leader in aquaculture development, and Enertech, the Kuwait-based innovator, investor
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches
Statement by Minister St-Onge on Human Rights Day
On Human Rights Day, let’s work together to promote freedom, equality and justice for every person. OTTAWA, ON, Dec. 10, 2023 /CNW/ – Today, on Human Rights Day, the Honourable Pascale St-Onge, Minister of Canadian Heritage made the following statement. “The Government of Canada
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at [email protected]
Freedom, Equality and Justice Lead to Peace
Human Rights Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW YORK, Dec. 10, 2023 /PRNewswire/ — Today we mark a milestone in history: the 75th anniversary of the Universal Declaration of Human Rights. As people around the world commemorate Human Rights Day, we must
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRNQ
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (OTC: CGRNQ). Such investors are advised to contact Robert S. Willoughby at [email protected]
